North Wales, PA, United States of America

Ashley Azar

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Drexel University. Active years: 2020-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ashley Azar

Introduction

Ashley Azar is an accomplished inventor based in North Wales, PA (US). She has made significant contributions to the field of dermatology through her innovative inventions. With a total of 3 patents, her work focuses on developing effective treatments for various dermal disorders.

Latest Patents

Ashley Azar's latest patents include compositions and methods for treating or preventing dermal disorders. These inventions address conditions such as dermal atrophy, pseudoscars, actinic keratosis, seborrheic or actinic keratoses, lentigines, focal areas of dermal thickening, and coarse wrinkles. In certain embodiments, the compositions comprise a therapeutically effective amount of a mTORC1 inhibitor and a dermatologically acceptable carrier.

Career Highlights

Ashley Azar is affiliated with Drexel University, where she continues to advance her research and innovations in dermatological treatments. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from various skin conditions.

Collaborations

Ashley collaborates with notable colleagues, including Christian Sell and Timothy Nacarelli, to further enhance her research and development efforts.

Conclusion

Ashley Azar's contributions to dermatology through her innovative patents demonstrate her commitment to improving skin health. Her work continues to inspire advancements in the treatment of dermal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…